Precigen Statistics
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.56+0.02 (+0.27%)
Market open · Delayed 15 min · as of Oct 8, 1:39 PM ET
Precigen by the numbers
Precigen has a market capitalization of $2.71 billion based on 358.04M shares outstanding. With trailing EPS of $-1.04, Precigen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.6% above its 50-day average and 49.5% above its 200-day average.
Average daily trading volume is 5.02M shares, or about $37.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PGEN valuation vs. peer median
| Metric | PGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.71B | $2.57B | +5% |
| Avg. volume | 5.02M | 1.22M | +311% |
Peer median across 8 companies: ZLAB, MRVI, LQDA, MBX, RCUS, NAMS, ELVN, SUPN.
Valuation
- Market cap
- $2.71B
- Price / sales (latest FY)
- 279.51
- EPS (TTM)
- $-1.04
- Shares outstanding
- 358.04M
Price and trading
- Previous close
- 7.54
- Open
- 7.46
- Day range
- 7.40 – 7.60
- 52-week range
- 2.99 – 8.98
- 52-week change
- +127.79%
- Beta
- —
- Volume
- 1.27M
- Average volume
- 5.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2026
Additional statistics
- Market Cap
- 2.71B
- Forward Pe
- -34.36
- Eps
- -1.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.98
- Week52 Low
- 2.99
- Avg Volume
- 5.02M
- Shares Outstanding
- 358.04M
- Ma50
- 7.16
- Ma200
- 5.06
- Earnings Date
- Aug 4, 2026
- Pct From52w High
- -15.81%
- Pct From52w Low
- 152.84%